Ratings and price targets from Mizuho analysts, and how many of their targets were reached. Latest call 19 November 2026.
1,409 Buy, 771 Hold and 80 Sell from 31 October 2025 to 30 October 2026. 1,108 target raises and 772 cuts.
Targets set above the share price from 2008 to October 2025. Across all firms the figure is 59.2%. How we measure.
Share of the 417 stocks with a sector on AnaChart.
| Analyst | Ratings, 12 mo | Price targets | Stocks | Avg upside | Targets met | Last call |
|---|---|---|---|---|---|---|
| John Roberts | Buy 57%Hold 35%Sell 8% | 1,312 | 74 | +40% | 19 Nov 2026 | |
| David Bellinger | Buy 54%Hold 45%Sell 2% | 347 | 36 | +17.5% | 19 Nov 2026 | |
| Gregg Moskowitz | Buy 60%Hold 36%Sell 4% | 1,805 | 79 | +27.2% | 19 Nov 2026 | |
| Brett Linzey | Buy 64%Hold 31%Sell 5% | 458 | 54 | +12.1% | 19 Nov 2026 | |
| Dan Dolev | Buy 69%Hold 30%Sell 2% | 1,388 | 74 | +33.8% | 19 Nov 2026 | |
| Benjamin Chaiken | Buy 87%Hold 6%Sell 8% | 599 | 46 | +41.1% | 19 Nov 2026 | |
| Maheep Mandloi | Buy 34%Hold 52%Sell 15% | 394 | 39 | +18.7% | 18 Nov 2026 | |
| James Lee | Buy 63%Hold 38%Sell 0% | 962 | 62 | +52.9% | 18 Nov 2026 | |
| Gabriel Moreen | Buy 74%Hold 26%Sell 0% | 952 | 72 | +13.1% | 18 Nov 2026 | |
| Wei Fang | Buy 100%Hold 0%Sell 0% | 69 | 10 | +62.1% | 18 Nov 2026 | |
| Yaron Kinar | Buy 46%Hold 51%Sell 3% | 864 | 65 | +9.4% | 17 Nov 2026 | |
| Vijay Rakesh | Buy 77%Hold 18%Sell 5% | 2,516 | 72 | +20% | 16 Nov 2026 | |
| Vikram Malhotra | Buy 53%Hold 40%Sell 7% | 1,005 | 102 | +15% | 16 Nov 2026 | |
| Nitin Kumar | Buy 48%Hold 48%Sell 5% | 1,962 | 120 | +28.3% | 16 Nov 2026 | |
| Graig Suvannavejh | Buy 91%Hold 9%Sell 0% | 703 | 89 | +62.4% | 16 Nov 2026 | |
| Sean Kennedy | Buy 70%Hold 30%Sell 0% | 57 | 10 | +24.9% | 16 Nov 2026 | |
| Steve Valiquette | Buy 50%Hold 48%Sell 3% | 467 | 57 | +20.6% | 13 Nov 2026 | |
| Ann Hynes | Buy 77%Hold 23%Sell 0% | 1,325 | 80 | +80.3% | 11 Nov 2026 | |
| Anthony Petrone | Buy 83%Hold 17%Sell 0% | 812 | 73 | +37.4% | 10 Nov 2026 | |
| Anthony Crowdell | Buy 37%Hold 63%Sell 0% | 1,225 | 84 | +11.1% | 9 Nov 2026 | |
| Nick Setyan | Buy 41%Hold 58%Sell 1% | 1,530 | 47 | +10.8% | 9 Nov 2026 | |
| Lloyd Walmsley | Buy 70%Hold 30%Sell 0% | 810 | 36 | +18.5% | 30 Oct 2026 | |
| Michael Romanelli | Buy 50%Hold 50%Sell 0% | 24 | 4 | +9.5% | 15 Oct 2026 | |
| William Janela | Buy 46%Hold 33%Sell 21% | 211 | 38 | +30.2% | 15 Oct 2026 | |
| Siti Panigrahi | Buy 73%Hold 25%Sell 2% | 978 | 74 | +21.2% | 6 Oct 2026 | |
| Haendel St. Juste | Buy 64%Hold 36%Sell 0% | 320 | 37 | +21.5% | 24 Sep 2026 | |
| Vincent Lovaglio | n/a | 162 | 17 | +37.7% | 3 Sep 2026 | |
| Ravi Vaidya | Buy 36%Hold 64%Sell 0% | 43 | 8 | +5.3% | 2 Sep 2026 | |
| Matthew Broome | Buy 63%Hold 38%Sell 0% | 166 | 9 | +16.9% | 2 Sep 2026 | |
| Salim Syed | Buy 92%Hold 8%Sell 0% | 465 | 29 | +96.1% | 1 Sep 2026 | |
| Mara Goldstein | Buy 75%Hold 25%Sell 0% | 277 | 51 | +97.5% | 18 Aug 2026 | |
| Joseph Catanzaro | Buy 91%Hold 9%Sell 0% | 353 | 49 | +70.1% | 12 Aug 2026 | |
| Paul Fremont | Buy 33%Hold 67%Sell 0% | 118 | 9 | +12.8% | 3 Aug 2026 | |
| John Baumgartner | Buy 63%Hold 26%Sell 11% | 457 | 35 | +28.7% | 31 Jul 2026 | |
| Edlain Rodriguez | Buy 31%Hold 56%Sell 13% | 108 | 15 | +14.8% | 14 Jul 2026 | |
| Uy Ear | Buy 89%Hold 11%Sell 0% | 219 | 29 | +107.7% | 2 Jul 2026 | |
| Omotayo Okusanya | Buy 100%Hold 0%Sell 0% | 89 | 13 | +11.5% | 1 Jul 2026 | |
| Robert Mosca | Buy 0%Hold 100%Sell 0% | 69 | 7 | -3.4% | 17 Feb 2026 | |
| Chris Kapsch | n/a | 116 | 13 | +55.6% | 15 Dec 2025 |
Analysts with a call in the past 12 months, latest first. Price targets, upside and targets met are each analyst's full Mizuho record, as on AnaChart stock pages, shown from 5 targets. Updated daily.
| Date | Stock | Analyst | Action | Price target | Rating |
|---|---|---|---|---|---|
| 19 Nov 2026 | ECL | John Roberts | Raised | $327 → $350 | Buy |
| 19 Nov 2026 | LOW | David Bellinger | Cut | $250 → $248 | Buy |
| 19 Nov 2026 | PANW | Gregg Moskowitz | Raised | $28.33 → $440 | Buy |
| 19 Nov 2026 | ROK | Brett Linzey | Cut | $430 → $415 | Hold |
| 19 Nov 2026 | TGT | David Bellinger | Raised | $122 → $168 | Hold |
| 19 Nov 2026 | PICS | Dan Dolev | Cut | $16 → $8 | Buy |
| 19 Nov 2026 | VIK | Benjamin Chaiken | Raised | $82 → $122 | Buy |
| 18 Nov 2026 | HD | David Bellinger | Cut | $390 → $385 | Buy |
| 18 Nov 2026 | NXT | Maheep Mandloi | Raised | $101 → $104 | Hold |
| 18 Nov 2026 | JD | James Lee | Cut | $41 → $34 | Buy |
| 18 Nov 2026 | SR | Gabriel Moreen | Raised | $88 → $96 | Buy |
| 18 Nov 2026 | TME | Wei Fang | Cut | $15 → $14 | Buy |
| 17 Nov 2026 | AFL | Yaron Kinar | Raised | $117 → $118 | Sell |
| 17 Nov 2026 | COST | David Bellinger | Raised | $1,065 → $1,150 | Buy |
| 17 Nov 2026 | EQH | Yaron Kinar | Cut | $66 → $65 | Buy |
| 17 Nov 2026 | FIVE | David Bellinger | Raised | $278 → $300 | Buy |
| 17 Nov 2026 | LNC | Yaron Kinar | Raised | $49 → $51 | Buy |
| 17 Nov 2026 | PRU | Yaron Kinar | Raised | $120 → $124 | Hold |
| 17 Nov 2026 | SWK | Brett Linzey | Raised | $105 → $120 | Buy |
| 17 Nov 2026 | CRBG | Yaron Kinar | Raised | $40 → $42 | Buy |
| 16 Nov 2026 | NVDA | Vijay Rakesh | Cut | $315 → $220 | Buy |
| 16 Nov 2026 | ARE | Vikram Malhotra | Cut | $60 → $50 | Buy |
| 16 Nov 2026 | CTRE | Vikram Malhotra | Cut | $45 → $44 | Buy |
| 16 Nov 2026 | CVI | Nitin Kumar | Cut | $52 → $47 | Sell |
| 16 Nov 2026 | DOC | Vikram Malhotra | Cut | $24 → $23 | Buy |
The most recent target from each analyst on each stock. Updated daily.
Which targets were reached, how fast, and each analyst's Performance Score on every stock they cover.
Goldman SachsJefferiesEvercoreH.C. WainwrightBAML
Mizuho analysts issued 2,260 ratings from 31 October 2025 to 30 October 2026: 1,409 Buy, 771 Hold and 80 Sell, on 615 stocks.
60.4% of the 9,695 targets its analysts set above the share price from 2008 to October 2025 were reached within 12 months. For those reached, the median wait was 77 days.
By price targets in the past 12 months: Vijay Rakesh (232), Nitin Kumar (172), Yaron Kinar (166).
Healthcare leads with 21% of the stocks it rated in the past 12 months.
Source: AnaChart records of analyst ratings and price targets. 12-month figures run from 31 October 2025 to 30 October 2026. Analysts and latest calls update daily. AnaChart publishes data about analysts' past calls. It is not investment advice.